Logos Global Management LP Nkarta, Inc. Transaction History

Logos Global Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.79 - $26.88 $16.3 Million - $34.3 Million	-1,275,777 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.67 - $38.76 $7.29 Million - $10.6 Million	273,395 Added 27.27%	1,275,777 $35.5 Million
Q2 2021 Aug 16, 2021	SELL	$23.94 - $36.68 $6.19 Million - $9.48 Million	-258,495 Reduced 20.5%	1,002,382 $31.8 Million
Q1 2021 May 17, 2021	SELL	$31.33 - $59.61 $13.2 Million - $25.1 Million	-421,301 Reduced 25.04%	1,260,877 $41.5 Million
Q4 2020 Feb 16, 2021	SELL	$27.03 - $75.62 $9.87 Million - $27.6 Million	-365,000 Reduced 17.83%	1,682,178 $103 Million
Q3 2020 Nov 16, 2020	BUY	$23.52 - $47.9 $48.1 Million - $98.1 Million	2,047,178 New	2,047,178 $61.5 Million

130

67.3M

142K

43.1K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $165M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.